Patients on chronic hemodialysis
Conditions
Interventions
Electrolyzed water hemodialysis group: hemodialysis (HD) treatment applying electrolyzed water for HD solution, HD performance
three times a week for 4-5 hours each session (Dialysate flow 500 ml/min), for up to 60 months.
Control hemodialysis group: HD treatment applying standard water for HD solution
HD performance , three times a week, 4-5 hours session each (dialysate flow
500 ml/min), for up to 60 months.
Sponsors
TOHOKU University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients who are on hemodialysis using water electrolysis system, and those who are on conventional standard system as control, are selected. The control patients need to be matched to the patients on water electrolysis system.
Exclusion criteria
Exclusion criteria: The following cases are not included in the study; critically ill patients due to malignant disease or other comorbidities, under 20 years old, those who cannot give consent by their selves.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary endpoints: all-cause of mortality and morbidities during the study period such as cardiac events (congestive heart failure, acute cardiac infarction, angina pectoris), stroke, infectious disease, and leg amputation due to arteriosclerosis obliterans | — |
Secondary
| Measure | Time frame |
|---|---|
| Secondary endpoints: the number of admissions, subjective assessments on general fatigue by dialysis, and blood parameters (hemoglobin, albumin, CRP) | — |
Countries
Japan
Contacts
Public ContactShigeru Kabayama
Japanese society for EW-HD Study secretariat of EW-HD
Outcome results
None listed